AbbVie (ABBV) Stock Price
$205.3 1.3%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
4 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on AbbVie, AI stock picks, stock alerts and much more.
ABBV AI Stock Analysis
AI stock analysis for ABBV is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like AbbVie (ABBV) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
AbbVie (ABBV) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of AbbVie (ABBV), currently trading at $205.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ABBV
-
AbbVie Inc.
-
Symbol
ABBV
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
363.2B
Similar Stocks
 |
Johnson & Johnson JNJ |
$163.7 0.4% |
5 |
 |
Eli Lilly and Company LLY |
$822.5 0.1% |
6 |
 |
Pfizer PFE |
$25.21 0.8% |
3 |
 |
Merck & Company MRK |
$89.23 1.9% |
4 |
 |
Novartis NVS |
$112.6 1.1% |
5 |
News
ABBV Alternative Data
Web Traffic
AbbVie receives an estimated 1.3M monthly visitors to abbvie.com.
-
Web Traffic
1280073
-
Change from Previous Month
1.7%
-
3 Month Change
13.4%
-
YoY Change
13.4%
News Mentions
AbbVie was mentioned 11 times in the news yesterday.
-
News Mentions
11
-
Daily Change
83.3%
-
1 Month Change
1000%
-
3 Month Change
37.5%
Reddit Mentions
AbbVie has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
AbbVie has 79,228 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
79228
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Facebook Engagement
AbbVie has engaged 969 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
969
-
Daily Change
2.2%
-
1 Month Change
372.7%
-
3 Month Change
46.8%
-
YoY Change
46.8%
Instagram Followers
AbbVie has 40,821 Instagram Followers on its main Instagram account, up by 1.8% over the last month.
-
Instagram Followers
40821
-
Daily Change
0.1%
-
1 Month Change
1.8%
-
3 Month Change
4.2%
-
YoY Change
4.2%
Youtube Subscribers
AbbVie has 6,940 subscribers on its main Youtube channel, up by 1.2% over the last month.
-
Youtube Subscribers
6940
-
Daily Change
0.1%
-
1 Month Change
1.2%
-
3 Month Change
4.5%
-
YoY Change
4.5%
LinkedIn Followers
1,550,197 are following AbbVie on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
1550197
-
Daily Change
0.1%
-
1 Month Change
1.7%
-
3 Month Change
4.8%
Job Postings
AbbVie currenly has an estimated 1,000 open job postings.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, AbbVie has 51,754 employees, up by 1.8% over the last month.
-
LinkedIn Employees
51754
-
Daily Change
0.1%
-
1 Month Change
1.8%
-
3 Month Change
5.2%
-
YoY Change
5.2%
Business Outlook
According to employee reviews, the business outlook among employees at AbbVie is 78 out of 100 (bullish).
-
Business Outlook
78
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
ABBV Financials
ABBV Key Metrics
-
Total Revenue
$15.1B
-
Net Income
-$22M
-
Earnings per Share
-$0.0181
-
Free cash flow
$6.8B
-
EBITDA
$535M
-
EBITDA Ratio
0.0354258
-
Total Assets
$135.2B
ABBV 2-year Revenue & Income
ABBV 2-year Free Cash Flow
ABBV Technicals
ABBV SMA
ABBV RSI
FAQ
What's the current price of AbbVie (ABBV) Stock?
The price of an AbbVie (ABBV) share is $205.3.
What's the market cap of AbbVie?
The current market cap of AbbVie is 363.2B.
Should I buy or sell ABBV?
AbbVie shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, AbbVie is better viewed as a hold or accumulate position while waiting for further developments.
Is AbbVie a good investment?
The current analysis of AbbVie's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in AbbVie's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy AbbVie (ABBV) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for AbbVie stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to AbbVie (ABBV) that investors often compare it to?
AbbVie (ABBV) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, Pfizer, Merck & Company and Novartis.
What is the forecast for AbbVie's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast AbbVie's stock price to be around $204 in 2026. Starting from the current price of $205.3, this represents a 0.6% change in price, indicating a neutral outlook for the stock.
How to buy AbbVie (ABBV) Stock?
AbbVie stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy AbbVie shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.